• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间变性甲状腺癌的发病率在上升吗:一项基于人群的流行病学研究。

Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study.

作者信息

Janz Tyler A, Neskey David M, Nguyen Shaun A, Lentsch Eric J

机构信息

Medical University of South Carolina, 135 Rutledge Ave., Charleston, SC., 29425, USA.

出版信息

World J Otorhinolaryngol Head Neck Surg. 2018 Aug 11;5(1):34-40. doi: 10.1016/j.wjorl.2018.05.006. eCollection 2019 Mar.

DOI:10.1016/j.wjorl.2018.05.006
PMID:30775700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6364517/
Abstract

OBJECTIVE

To provide an understanding of the incidence of anaplastic thyroid cancer within the United States.

METHODS

Patients in the Surveillance, Epidemiology, and End Results (SEER) database were included from 1973 to 2014 based on a diagnosis of anaplastic thyroid cancer using ICD O-3 codes. Patients were categorized into cohorts based on their year of diagnosis.

RESULTS

1527 patients were diagnosed with anaplastic thyroid cancer within the SEER 18 registries. The age-adjusted incidence rate was 0.2 per 1,000,000 people (95% : 0.0-0.5) in 1973 and was 1.2 per 1,000,000 people (95% : 0.8-1.6) in 2014 (average annual percent change: 3.0% [95% : 2.2%-3.7%]). Patients tended to be of older age (mean age: 70.5 [range 15.0-102.0]), of female sex (62.8%), and Caucasian (81.1%). Finally, survival over time remained the same, as median disease specific survival months was 4.00 (95% : 2.26-5.74) from 1995 to 1999 and 4.00 (95% : 3.26-4.74) from 2010 to 2014.

CONCLUSIONS

The incidence rate of anaplastic thyroid cancer has increased from 1973 to 2014. Interestingly, median survival in months did not greatly change overtime. Based on this increasing incidence, physicians must act appropriately to identify patients with anaplastic thyroid cancer as it possesses a high morbidity and mortality.

LEVEL OF EVIDENCE

摘要

目的

了解美国间变性甲状腺癌的发病率。

方法

根据国际疾病分类肿瘤学第三版(ICD O - 3)编码诊断为间变性甲状腺癌,纳入监测、流行病学和最终结果(SEER)数据库中1973年至2014年的患者。根据诊断年份将患者分为不同队列。

结果

在SEER的18个登记处,有1527例患者被诊断为间变性甲状腺癌。1973年年龄调整后的发病率为每100万人0.2例(95%置信区间:0.0 - 0.5),2014年为每100万人1.2例(95%置信区间:0.8 - 1.6)(年均变化百分比:3.0% [95%置信区间:2.2% - 3.7%])。患者倾向于年龄较大(平均年龄:70.5岁[范围15.0 - 102.0岁]),女性(62.8%),白种人(81.1%)。最后,随着时间推移生存率保持不变,1995年至1999年疾病特异性生存月中位数为4.00(95%置信区间:2.26 - 5.74),2010年至2014年为4.00(95%置信区间:3.26 - 4.74)。

结论

1973年至2014年间变性甲状腺癌的发病率有所上升。有趣的是,生存月中位数随时间变化没有太大改变。基于这种发病率的上升,医生必须采取适当行动来识别间变性甲状腺癌患者,因为该病具有高发病率和高死亡率。

证据水平

4级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0367/6364517/4c80fbc3bf64/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0367/6364517/42d38f010285/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0367/6364517/1ad28bf60003/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0367/6364517/4c80fbc3bf64/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0367/6364517/42d38f010285/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0367/6364517/1ad28bf60003/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0367/6364517/4c80fbc3bf64/gr3.jpg

相似文献

1
Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study.间变性甲状腺癌的发病率在上升吗:一项基于人群的流行病学研究。
World J Otorhinolaryngol Head Neck Surg. 2018 Aug 11;5(1):34-40. doi: 10.1016/j.wjorl.2018.05.006. eCollection 2019 Mar.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).浆细胞骨髓瘤——按年龄、性别、种族、分期、队列入组时间和疾病持续时间对三种浆细胞骨髓瘤国际疾病分类肿瘤学形态进行的20年生存和死亡率比较:对1973 - 2014年诊断的111,041例病例的系统评价:(监测、流行病学和最终结果*统计8.3.4)
J Insur Med. 2018;47(4):203-211. doi: 10.17849/insm-47-04-1-9.1. Epub 2019 Jan 22.
4
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.1974 - 2013年美国甲状腺癌发病率和死亡率趋势
JAMA. 2017 Apr 4;317(13):1338-1348. doi: 10.1001/jama.2017.2719.
5
The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis.间变性甲状腺癌的发病率及生存分析:一项监测、流行病学和最终结果(SEER)数据库分析
Am J Transl Res. 2019 Sep 15;11(9):5888-5896. eCollection 2019.
6
Pediatric thyroid cancer: An update from the SEER database 2007-2012.儿童甲状腺癌:来自监测、流行病学和最终结果(SEER)数据库2007 - 2012年的最新情况
Int J Pediatr Otorhinolaryngol. 2016 Oct;89:121-6. doi: 10.1016/j.ijporl.2016.08.005. Epub 2016 Aug 8.
7
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
8
In-depth analysis of thyroid cancer mortality.深入分析甲状腺癌死亡率。
Head Neck. 2021 Mar;43(3):977-983. doi: 10.1002/hed.26577. Epub 2020 Dec 12.
9
Analysis of Race and Gender Disparities in Incidence-Based Mortality in Patients Diagnosed with Thyroid Cancer from 2000 to 2016.2000年至2016年甲状腺癌确诊患者基于发病率的死亡率的种族和性别差异分析
Int J Gen Med. 2020 Dec 16;13:1589-1594. doi: 10.2147/IJGM.S280986. eCollection 2020.
10
Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.2004 - 2009年美国垂体肿瘤的描述性流行病学
J Neurosurg. 2014 Sep;121(3):527-35. doi: 10.3171/2014.5.JNS131819. Epub 2014 Jun 13.

引用本文的文献

1
Case Report: Remarkable and sustained remission of an anaplastic thyroid carcinoma patient to the combined treatment of multimodal radiotherapy, anlotinib and toripalimab.病例报告:一名间变性甲状腺癌患者经多模态放疗、安罗替尼和托瑞帕利单抗联合治疗后实现显著且持续的缓解。
Front Oncol. 2025 May 21;15:1491918. doi: 10.3389/fonc.2025.1491918. eCollection 2025.
2
NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma.晚期甲状腺癌的新见解:从机制到治疗:间变性甲状腺癌起源、生物学特性及治疗的分子见解
Eur Thyroid J. 2025 Jun 2;14(3). doi: 10.1530/ETJ-25-0057. Print 2025 Jun 1.
3

本文引用的文献

1
Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.间变性甲状腺癌的积极姑息治疗与生存情况
JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1128-32. doi: 10.1001/jamaoto.2015.2332.
2
The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk.患者年龄对甲状腺结节形成、多结节性及甲状腺癌风险的影响。
J Clin Endocrinol Metab. 2015 Dec;100(12):4434-40. doi: 10.1210/jc.2015-3100. Epub 2015 Oct 14.
3
Anaplastic Thyroid Carcinoma, Version 2.2015.间变性甲状腺癌,2015年第2版
Survival Analysis of Anaplastic Thyroid Carcinoma With Various Therapeutic Modalities: Twenty-Seven Years' Experience in a Single Cancer Center.
不同治疗方式下间变性甲状腺癌的生存分析:单一癌症中心27年的经验
World J Oncol. 2025 Feb;16(1):113-119. doi: 10.14740/wjon1988. Epub 2024 Dec 31.
4
Disproportionately Increased Incidence of Anaplastic Thyroid Cancer in the North Yorkshire Region: A UK Tertiary Centre Study.北约克郡地区间变性甲状腺癌发病率的异常增加:一项英国三级中心研究
Cureus. 2024 Oct 21;16(10):e72006. doi: 10.7759/cureus.72006. eCollection 2024 Oct.
5
Aggressive Types of Malignant Thyroid Neoplasms.侵袭性恶性甲状腺肿瘤类型
J Clin Med. 2024 Oct 14;13(20):6119. doi: 10.3390/jcm13206119.
6
Single-Institution Experience of Larotrectinib Therapy for Patients With Fusion-Positive Thyroid Carcinoma.拉罗替尼治疗融合阳性甲状腺癌患者的单机构经验
J Endocr Soc. 2024 Sep 9;8(10):bvae158. doi: 10.1210/jendso/bvae158. eCollection 2024 Aug 27.
7
European Society of Endocrine Surgeons (ESES) consensus statement on advanced thyroid cancer: definitions and management.欧洲内分泌外科学会(ESES)关于晚期甲状腺癌的共识声明:定义与管理
Br J Surg. 2024 Aug 2;111(8). doi: 10.1093/bjs/znae199.
8
An Overview on Prevalence and Detection Approaches of BRAF V600E Mutation in Anaplastic Thyroid Carcinoma: A Systematic Review and Meta-Analysis.间变性甲状腺癌中BRAF V600E突变的患病率及检测方法概述:一项系统评价和荟萃分析
Iran J Public Health. 2024 Jul;53(7):1496-1507. doi: 10.18502/ijph.v53i7.16044.
9
Prognostic Factors and Survival Outcomes in Squamous Cell Carcinoma of the Thyroid: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis.甲状腺鳞状细胞癌的预后因素和生存结果:一项监测、流行病学和最终结果(SEER)数据库分析
Cureus. 2024 Jun 27;16(6):e63326. doi: 10.7759/cureus.63326. eCollection 2024 Jun.
10
An overview of the contemporary diagnosis and management approaches for anaplastic thyroid carcinoma.间变性甲状腺癌的当代诊断与管理方法概述。
World J Clin Oncol. 2024 Jun 24;15(6):674-676. doi: 10.5306/wjco.v15.i6.674.
J Natl Compr Canc Netw. 2015 Sep;13(9):1140-50. doi: 10.6004/jnccn.2015.0139.
4
Anaplastic thyroid cancer.间变性甲状腺癌
Curr Opin Endocrinol Diabetes Obes. 2015 Oct;22(5):387-91. doi: 10.1097/MED.0000000000000189.
5
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER.美国临床内分泌医师协会和美国内分泌学会疾病状态临床综述:甲状腺癌发病率不断上升
Endocr Pract. 2015 Jun;21(6):686-96. doi: 10.4158/EP14466.DSCR.
6
The effects of race and ethnicity on thyroid cancer incidence.种族和族裔对甲状腺癌发病率的影响。
JAMA Otolaryngol Head Neck Surg. 2015 Apr;141(4):319-23. doi: 10.1001/jamaoto.2014.3740.
7
Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies.肥胖与甲状腺癌风险:来自21项观察性研究的荟萃分析证据
Med Sci Monit. 2015 Jan 22;21:283-91. doi: 10.12659/MSM.892035.
8
Current thyroid cancer trends in the United States.美国当前的甲状腺癌趋势。
JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):317-22. doi: 10.1001/jamaoto.2014.1.
9
Anaplastic thyroid carcinoma: a 25-year single-institution experience.间变性甲状腺癌:25年单机构经验
Ann Surg Oncol. 2014 May;21(5):1665-70. doi: 10.1245/s10434-014-3545-5. Epub 2014 Feb 20.
10
The changing face of thyroid cancer in a population-based cohort.基于人群的队列研究中甲状腺癌的变化面貌。
Cancer Med. 2013 Aug;2(4):537-44. doi: 10.1002/cam4.103. Epub 2013 Jun 26.